AMCP ASH 25 | AMCP ASH 25

AMCP ASH 2025

The 67th American Society of Hematology (ASH) Annual Meeting and Exposition will take place December 6-9, 2025, in Orlando, Florida, and online. The meeting is the world’s most comprehensive hematology event of the year, featuring hundreds of sessions and thousands of abstracts.

Day 1

Multidisciplinary Strategy Improves Vaccination Adherence

December 8, 2025

Point-of-Care Ultrasound for Diagnosis of DVT and Venous Reflux

December 8, 2025

Study: SCD Pain Clinic Is Significantly More Efficient and Less Expensive...

December 8, 2025

New Dual BTK-MALT1 Fusion Inhibitors Show Promise in Mantle Cell Lymphoma

December 8, 2025

Day 2

Digital Platform Has Early Success in Managing Rare Blood Disorder

December 8, 2025

$Study: Obinutuzumab Safe and Effective in Relapsed or Refractory Follicular Lymphoma$

Study: Obinutuzumab Safe and Effective in Relapsed or Refractory Follicular Lymphoma

December 8, 2025

Institution Describes Challenges after Release of Commercial Formulation of Hydroxyurea

December 8, 2025

Bexobrutideg Produces Rapid and Durable Responses in CLL

December 8, 2025

Day 3

APP-Led Program Lessens Time to Diagnosis and Access to Care

December 12, 2025

Graded Mobility Better at Predicting VTE

December 12, 2025

Study Sets Threshold for Cost-Effective Iron-Deficiency Screening

December 12, 2025

Assessing Approvals and Costs of Classical Hematology Drugs

December 12, 2025

Day 4

Frailty Markers Affect Outcomes Among Patients Receiving CAR T-Cell Therapy

December 15, 2025

“Hospital at Home” Program Is Safe and Useful in Hematologic Malignancies

December 15, 2025

New Efficacy and Safety Data on BTK Degrader BGB-16673

December 15, 2025

$Second-Generation CAR T-Cell Therapy Effective in Relapsed/Refractory MCL$

Second-Generation CAR T-Cell Therapy Effective in Relapsed/Refractory MCL

December 15, 2025

Advertisement

Quick Links

Day 1 Day 2 Day 3 Day 4